SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021946
Filing Date
2020-05-06
Accepted
2020-05-06 16:17:13
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20200331.htm 10-Q 1286327
2 EX-31.1 abio-ex311_9.htm EX-31.1 8575
3 EX-31.2 abio-ex312_7.htm EX-31.2 8533
4 EX-32.1 abio-ex321_8.htm EX-32.1 11181
  Complete submission text file 0001564590-20-021946.txt   3349835

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20200331.xml EX-101.INS 447287
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20200331.xsd EX-101.SCH 30503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20200331_cal.xml EX-101.CAL 23805
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20200331_def.xml EX-101.DEF 74882
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20200331_lab.xml EX-101.LAB 257648
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20200331_pre.xml EX-101.PRE 176600
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 20852837
SIC: 2835 In Vitro & In Vivo Diagnostic Substances